Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery

• Status: Completed
• Trial end date: 2020-11-01
• Target enrollment: 0
• Participant gender: Male

Summary

Randomization (1:1) of male patients, over age 50, undergoing elective spine surgery to tamsulosin versus a placebo.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Maine Medical Center; MaineHealth
• Treatments: Tamsulosin

Criteria

Inclusion Criteria

• Male patient age 50 - 85 years

• Undergoing elective spine surgery at least 5 days after enrollment

• Preop visit done at office practice

Exclusion Criteria:

• Currently on tamsulosin or other alpha-adrenergic blocking drug

• Allergy to tamsulosin

• Allergy to lactose

• Serious or life-threatening allergy to sulfa drugs

• Emergent procedure

• History of spinal trauma, spinal infection or spinal cord tumor

• Pre-existing indwelling urinary catheter

• History of orthostatic hypotension or current orthostatic hypotension

• History of prostate, urethral or bladder surgery

• Renal failure

• Non-English speaking

• Unable to provide informed consent